A:FOLFOX4+ATRA

2 trials

Sponsors

Eastern Hepatobiliary Surgery Hospital, Eastern Hepatobiliary Surgical Hospital

Conditions

advanced hepatocelullar carcinomaliver cancer

Phase 2

A randomized controlled trial for comparing FOFLOX4 versus ARTA+FOLFOX4 in the treatment of hepatocelullar carcinoma with extrahepatic metastasis

RecruitingChiCTR-IIR-17012916

Eastern Hepatobiliary Surgical Hospitalliver cancer

Start: 2018-06-30Updated: 2018-09-03

Phase 3

All-Trans-Retinoic Acid (ATRA) Combined with FOLFOX4 versus Atilizumab Combined with Bevacizumab (T+A) in HCC Patients with Lung Metastasis:A Randomized Controlled Trial

Active, not recruitingChiCTR2300071896

Eastern Hepatobiliary Surgery Hospitaladvanced hepatocelullar carcinoma

Start: 2023-06-01Updated: 2023-06-12

Related Papers

All-trans-retinoic acid (ATRA) plus oxaliplatin plus 5-fluorouracil/leucovorin (FOLFOX) versus FOLFOX alone as palliative chemotherapy in patients with advanced hepatocellular carcinoma and extrahepatic metastasis: study protocol for a randomized controlled trial

Trials2019-04-2910 citations